glp 1 agonism GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus GLP-1 Receptor Agonists and Research
Description
16(1): p
American association of clinical endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity
GLP-1 injections increase insulin secretion in response to food intake and help the body use insulin more effectively
Non-alcoholic fatty liver disease and obesity: Biochemical metabolic and clinical presentations
This so-called incretin effect is attributed to the insulinotropic action of gut hormones, particularly: Glucose-dependent insulinotropic polypeptide (GIP) Glucagon-like peptide 1 (GLP-1)
Food and Drug Administration (FDA-d)
